Ergoteles LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$628,528
-42.2%
115,751
-47.4%
0.02%
-30.3%
Q2 2022$1,087,000
+295.3%
220,100
+508.0%
0.03%
+230.0%
Q1 2022$275,000
-17.7%
36,200
+10.5%
0.01%
-23.1%
Q4 2021$334,000
-51.0%
32,754
-35.5%
0.01%
-48.0%
Q3 2021$681,00050,7670.02%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders